SALARIUS PHARMACEUTICALS INC (SLRX) Stock Income Statement
USA - NASDAQ:SLRX - US79400X5032 - Common Stock
2 USD
-0.44 (-18.03%)
1.14 USD
-0.86 (-43%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1.84M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 5.18M | 5.73M | 12.89M | 22.98M | 14.65M | |||
| Research and Development | 504.40K | 770.00K | 7.17M | 15.84M | 8.55M | |||
| Selling, General, and Administrative Expenses | 4.67M | 4.96M | 5.72M | 7.14M | 6.10M | |||
| Operating Income | -5.18M | -5.73M | -12.89M | -22.98M | -12.81M | |||
| Interest Income/Expense | 76.10K | 158.50K | 352.30K | 233.20K | 44.70K | |||
| Other Income/Expense | null | null | null | null | 0 | |||
| Non Recurring Items | null | null | 0 | -8.87M | null | |||
| Income Before Taxes | -5.10M | -5.58M | -12.54M | -31.61M | -12.77M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -5.10M | -5.58M | -12.54M | -31.61M | -12.77M | |||
| EBITDA | -5.18M | -5.73M | -12.88M | -22.97M | -12.79M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -48.73799999999999 | -86.91 | -460.95 | -1.78K | -925.9 | |||
| Non GAAP EPS | null | null | null | -86.4 | -60 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | -693.85% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -696.28% | |||
All data in USD